Semler Scientific (SMLR) Competitors $40.19 +0.52 (+1.31%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$40.24 +0.05 (+0.13%) As of 04:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMLR vs. WRBY, LIVN, EYE, NVCR, LMAT, ENOV, CNMD, CDRE, AORT, and ESTAShould you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), CONMED (CNMD), Cadre (CDRE), Artivion (AORT), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. Semler Scientific vs. Its Competitors Warby Parker LivaNova National Vision NovoCure LeMaitre Vascular Enovis CONMED Cadre Artivion Establishment Labs Warby Parker (NYSE:WRBY) and Semler Scientific (NASDAQ:SMLR) are both medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Do analysts recommend WRBY or SMLR? Warby Parker presently has a consensus target price of $22.88, indicating a potential downside of 6.69%. Semler Scientific has a consensus target price of $89.00, indicating a potential upside of 121.45%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Semler Scientific is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 9 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.53Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is WRBY or SMLR more profitable? Warby Parker has a net margin of -1.79% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-1.79% -2.48% -1.29% Semler Scientific -60.69%19.75%15.47% Do institutionals and insiders have more ownership in WRBY or SMLR? 93.2% of Warby Parker shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 18.2% of Warby Parker shares are held by insiders. Comparatively, 30.2% of Semler Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger earnings and valuation, WRBY or SMLR? Semler Scientific has lower revenue, but higher earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M3.32-$20.39M-$0.12-204.29Semler Scientific$49.23M11.26$40.90M-$2.61-15.40 Does the media favor WRBY or SMLR? In the previous week, Warby Parker had 1 more articles in the media than Semler Scientific. MarketBeat recorded 7 mentions for Warby Parker and 6 mentions for Semler Scientific. Warby Parker's average media sentiment score of 1.16 beat Semler Scientific's score of 0.44 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Semler Scientific 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, WRBY or SMLR? Warby Parker has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. SummarySemler Scientific beats Warby Parker on 9 of the 17 factors compared between the two stocks. Get Semler Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMLR vs. The Competition Export to ExcelMetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$546.97M$6.59B$5.49B$9.45BDividend YieldN/A1.31%4.01%4.03%P/E Ratio-15.4025.7328.4719.90Price / Sales11.2673.66410.1985.18Price / Cash8.8620.0435.9658.29Price / Book1.614.678.365.67Net Income$40.90M$176.14M$3.24B$258.18M7 Day Performance-5.90%1.07%3.13%2.81%1 Month Performance-4.29%4.00%10.98%13.53%1 Year Performance18.21%4.97%34.54%17.68% Semler Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMLRSemler Scientific2.6966 of 5 stars$40.19+1.3%$89.00+121.4%+17.3%$546.97M$49.23M-15.40120WRBYWarby Parker2.8884 of 5 stars$23.02+3.7%$22.88-0.6%+52.9%$2.41B$795.09M-191.803,780Positive NewsInsider TradeLIVNLivaNova3.3563 of 5 stars$43.97-0.8%$59.29+34.8%-19.7%$2.40B$1.25B-10.752,900Upcoming EarningsEYENational Vision2.9176 of 5 stars$25.01+2.2%$22.10-11.6%+89.2%$1.98B$1.82B-75.7913,411NVCRNovoCure3.6992 of 5 stars$17.42-1.0%$32.43+86.2%-13.7%$1.94B$605.22M-11.541,488Upcoming EarningsLMATLeMaitre Vascular2.7708 of 5 stars$84.09+0.5%$97.83+16.3%-9.0%$1.90B$226.26M42.47490Positive NewsAnalyst ForecastENOVEnovis2.9015 of 5 stars$31.91-6.2%$55.60+74.3%-40.5%$1.82B$2.15B-2.297,367CNMDCONMED4.8021 of 5 stars$50.04-2.4%$62.20+24.3%-32.0%$1.55B$1.31B13.173,900Upcoming EarningsCDRECadre3.4411 of 5 stars$33.47+2.1%$37.50+12.0%-13.6%$1.36B$567.56M35.232,284Positive NewsDividend AnnouncementAORTArtivion2.7566 of 5 stars$31.68+0.7%$32.40+2.3%+10.9%$1.35B$390.08M-63.361,600ESTAEstablishment Labs2.2402 of 5 stars$45.53+1.4%$51.80+13.8%-8.2%$1.32B$166.02M-14.691,018 Related Companies and Tools Related Companies Warby Parker Alternatives LivaNova Alternatives National Vision Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives Enovis Alternatives CONMED Alternatives Cadre Alternatives Artivion Alternatives Establishment Labs Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMLR) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMLR Stock Alerts